Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Accounts Payables (2023 - 2026)

Adagio Medical Holdings has reported Accounts Payables over the past 4 years, most recently at $1.2 million for Q1 2026.

  • Quarterly Accounts Payables fell 54.02% to $1.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2026, down 54.02% year-over-year, with the annual reading at $1.1 million for FY2025, 61.9% down from the prior year.
  • Accounts Payables was $1.2 million for Q1 2026 at Adagio Medical Holdings, up from $1.1 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $4.4 million in Q3 2024 and troughed at $1.0 million in Q3 2025.
  • The 4-year median for Accounts Payables is $2.0 million (2025), against an average of $2.3 million.
  • Year-over-year, Accounts Payables decreased 25.85% in 2024 and then tumbled 76.83% in 2025.
  • A 4-year view of Accounts Payables shows it stood at $3.8 million in 2023, then fell by 25.85% to $2.8 million in 2024, then crashed by 61.9% to $1.1 million in 2025, then rose by 12.48% to $1.2 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Accounts Payables are $1.2 million (Q1 2026), $1.1 million (Q4 2025), and $1.0 million (Q3 2025).